Is Congress harming pharmaceutical research by limiting enforcement of improvement patents?
Nick Colic
Advertisement
Articles by Nick Colic
Advertisement
Latest Updated Articles
- Attacks on Pharmaceutical Improvement Patents
Published: August 21st 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Johnson and Johnson’s Darzalex Faspro for Adults with High-Risk Smoldering Multiple Myeloma
2
Pharmaceutical Executive Daily: Lilly and Novo Nordisk Bring GLP-1s to TrumpRX
3
FDA Continues to Expand National Priority Voucher Program
4
In Obesity Care, NPs and PAs Are the Influencers Marketers Can’t Ignore
5
